✦ LIBER ✦

The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes

✍ Scribed by Thomas M. Braun

Book ID: 114186913
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 148 KB
Volume: 23
Category: Article
ISSN: 0197-2456
DOI: 10.1016/s0197-2456(01)00205-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continual reassessment methods in phase

Continual reassessment methods in phase I trials of the combination of two drugs in oncology

✍ Andrew Kramar; Anne Lebecq; Emmanuel Candalh 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Most phase I trials in oncology use standard methods for treating successive groups of patients with increasing doses in order to determine the maximum tolerated dose (MTD). These methods have been criticized because they treat many patients at suboptimal dose levels, and do not provide an accurate

Phase I study ofcontinuousMKC-1 in patie

Phase I study ofcontinuousMKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design

✍ Amye Tevaarwerk, George Wilding, Jens Eickhoff, Rick Chappell, Carolyn Sidor, Ja 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 128 KB

A simulation-based comparison of the tra

A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials

✍ Arzu Onar-Thomas; Zang Xiong 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 600 KB